It is important to note that the principle of resistance established here might have broader implications in other cancers since NAA40 is upregulated in various types of tumours [4], many of which are routinely treated by chemotherapy regimens encompassing anti-metabolite agents and may develop non-genetically induced chemoresistance [32, 33]. The gene discussed is NAA40; the disease is cancer.